Product Details
The NP's Role in Substance Use Disorder Management: Screening, Diagnosis, and Treatment

View Special Offer!
- Credit(s): 3 Contact Hour(s) of CE; Pharmacology of which may be applied towards Pharmacology
- Program Number: 24106927
- Original Program Date: October 18, 2024
- Duration: 2 hours 50 minutes
- Access: Available until April 30, 2026
OnDemand
- Non-Member Price
- $60.00
- Member Price
  AANP Membership Benefit
- $30.00

Description

Activity Duration

Content Expires:

April 30, 2026 (11:55 p.m. CT)
CE for this activity will not be available after this date.

This activity includes closed captioning.

Overview

Substance Use Disorders (SUDs) are chronic, treatable diseases that should be managed using principles similar to those of other chronic illnesses using a nonjudgmental and empathetic approach. This program discusses identifying, screening and the management of various SUDs including opioids and alcohol.

This activity can be used towards meeting the DEA requirement for the one-time 8-hour continuing education training.

Objectives

Review the shared neurobiologic mechanisms of addiction.
Review the impact of substance use disorders in the US.
Describe evidence-based treatment recommendations for patients with SUD.

Speakers
Colleen Barry, MSN, APRN, FNP-C, CARN-AP, CSAP
Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN

Peer Reviewed by Dr. Marissa Abram, PhD, PMHNP-BC, CARN-AP, FIAAN

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

The speakers have the following disclosures:

Colleen and Laura have no relevant financial relationships to disclose.

All Planners involved in this activity have no relevant financial relationships to disclose.
This program was developed through internal funding and approval of the AANP Board of Directors.

Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete the educational content:
- Take the Pretest.
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
- Complete the activity Post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button.
  - A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
  - A copy of the certificate will be automatically added to your AANP CE Tracker.

Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.

Credits

3 Contact Hour(s) of CE ,
0.75 of which may be applied towards Pharmacology

Faculty

Colleen Barry, MSN, APRN, FNP-C, CARN-AP, CSAPBio

Colleen Barry, MSN, APRN, FNP-C, CARN-AP, CSAP Bio

Colleen is an advanced practice nurse specializing in primary care and addiction medicine. Colleen has experience working in a behavioral health setting providing care to patients with mental health and substance use disorders. She has provided primary care services during in-patient psychiatric admissions and primary care and medicated assisted treatment to women in a substance use residential treatment facility.

Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAANBio

Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN Bio

A Fellow in the American Academy of Nursing & the American Association of Nurse Practitioners, Dr. Laura Leahy is a Triple Board-Certified Child, Adolescent & Adult Psychiatric & Addictions Advanced Practice Nurse and Master Clinician in Psychopharmacology. She founded her private practice, APNSolutions, LLC, in Sewell, NJ in January 2011.As a clinician-educator, with expertise in psychopharmacology & substance use disorders, Dr. Leahy has served as Psychiatric NP program director and taught psychopharmacology at leading universities. She authored two psychopharmacology clinical texts, numerous book chapters and peer-reviewed journal articles, and has been an invited speaker at countless conferences across the nation. She has received multiple awards for her innovation & excellence in clinical practice as well as the precepting of students. Dr Leahy is the current Co-Chair of the Addictions Council of the American Psychiatric Nurses Association (APNA) & represents Nursing as a Lead Mentor for SAMSHA’s Providers Clinical Support System. She has briefed Congress on nursing’s role in combatting the opioid epidemic influencing the passage of the SUPPORT Act (2018) and has served as expert consultant to Seton Hall University in writing the training curriculum needed to obtain a DATA 2000 Waiver for physicians, advanced practice nurses and physician assistants.Dr Leahy has testified before both branches of the NJ legislature to advocate for full practice authority and access to psychiatric & substance use treatment. She is an active member of & holds many board appointments within state & national professional organizations. She is the 4th APN to have obtained prescriptive practice in NJ and was the 1st APN to obtain her DEA-X Waiver to prescribe and treat Opioid Use Disorder with buprenorphine. Dr Leahy is an honors graduate of Duke University(BS), the University of Pennsylvania(BSN/MSN) & Drexel University (DrNP).

Materials

	Post Test Review (2) (633 KB)
	Handout - Presentation Slides (74) (2 MB)

Desktop Site